About Tilray Brands Inc.

Tilray Brands Inc., formed through the merger of Tilray and Aphria, has become one of the world's largest cannabis companies with diverse operations spanning medical cannabis, adult-use cannabis, hemp foods, and alcoholic beverages. The company has built global market positions while navigating evolving regulatory environments. TLRY stock price reflects both the company's market leadership and the volatility inherent in emerging cannabis markets.

Led by CEO Irwin Simon, Tilray has focused on operational integration, cost optimization, and strategic market expansion while building a diversified portfolio of cannabis and consumer products. The management team has successfully combined operations from multiple acquisitions while maintaining compliance across various regulatory jurisdictions. Leadership's strategic vision for building a global cannabis and consumer goods platform has been important for positioning the company and influencing TLRY stock price trajectory.

Tilray operates cannabis cultivation, processing, and distribution facilities across multiple countries, along with hemp food products and alcoholic beverage brands. The company serves medical patients, adult-use consumers, and wholesale customers through various brands and distribution channels. With cannabis legalization expanding globally, growing acceptance of cannabis products for medical and wellness applications, and Tilray's established international presence and diverse product portfolio, TLRY offers investors exposure to cannabis industry growth with global diversification, though regulatory uncertainties and market volatility create ongoing challenges requiring strategic adaptation and operational excellence.